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Abstract: Colorectal cancer (CRC) is the third most common cause of mortality in the United States
(US). Differences in CRC mortality according to race have been extensively studied; however, much
more understanding with regard to tumor characteristics’ effect on mortality is needed. The objective
was to investigate the association between race and mortality among CRC patients in the US during
2007–2014. A retrospective cohort study using data from the Surveillance, Epidemiology, and End
Results (SEER) Program, which collects cancer statistics through selected population-based cancer
registries during in the US, was conducted. The outcome variable was CRC-related mortality in
adult patients (≥18 years old) during 2007–2014. The independent variable was race of white, black,
Asian/Pacific Islander (API), and American Indian/Alaska Native (others). The covariates were, age,
sex, marital status, health insurance, tumor stage at diagnosis, and tumor size and grade. Bivariate
analysis was performed to identify possible confounders (chi-square tests). Unadjusted and adjusted
logistic regression models were used to study the association between race and CRC-specific mortality.
The final number of participants consisted of 70,392 patients. Blacks had a 32% higher risk of
death compared to whites (adjusted odds ratio (OR) 1.32; 95% confidence interval (CI) 1.22–1.43).
Corresponding OR for others were 1.41 (95% CI 1.10–1.84). API had nonsignificant adjusted odds
of mortality compared to whites (0.95; 95% CI 0.87–1.03). In conclusion, we observed a significant
increased risk of mortality in black and American Indian/Alaska Native patients with CRC compared
to white patients.
Keywords: race; blacks; colorectal cancer; death

1. Introduction
Colorectal cancer (CRC) is the third most commonly diagnosed cancer in the United States
(US) among all races and both sexes [1,2]. It has been estimated that 100,000 new cases of CRC
are diagnosed each year [1]. The incidence and mortality of colorectal cancer has been decreasing
during the last two decades; however, a divergence in mortality still exists between different races [3].
Research showed that whites have a higher survival rate in colon cancer than blacks. The lack of
providing the appropriate healthcare burdens cancer screening programs and delays tumor diagnosis
to advanced stages [4]. Therefore, blacks are more likely to present with advanced tumors at the time
of diagnosis compared to other races [4]. Consequently, blacks have higher mortality rates of colorectal
cancer [5,6]. Even though tumor characteristics have been extensively studied, tumor size is yet to be
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fully addressed as a confounding factor for CRC-related mortality. Furthermore, previous studies did
not control for tumor size in their analysis, as tumor size at diagnosis may differ between races.
Differences in mortality among people of different race may be due to socioeconomic status, age,
sex, stage of tumor at time of diagnosis, and colorectal cancer screening programs [7–10]. However,
even after controlling for some of these characteristics, differences in survival persisted [11].
Some studies reported that the stage of tumor at the time of diagnosis was the major factor
explaining the mortality disparity among different races in the US [12].
A recent study revealed that when races were compared, assuming an equal access to health care,
the race–survival disparity disappeared in patients above 50 years of age [7]. Young black Americans
(<50 years old) have a higher risk of death than their white American counterparts; furthermore,
authors observed an increased risk of death in only black men compared to white, with no difference
among women [13]. In another study which investigated the differences in colorectal cancer by race
and insurance, authors concluded that patients with no insurance or those who have Medicaid have
lower survival rates than those with private insurance. However, there is no difference in the receipt of
treatment for colorectal cancer between whites and blacks [14].
The aim of this study was to investigate the association between race and mortality among patients
with CRC in the US during 2007–2014.
2. Materials and Methods
2.1. Study Design and Population
The design of this secondary data analysis was a retrospective cohort study using the available
data from the Surveillance, Epidemiology, and End Results (SEER) Program of the National
Cancer Institute [15]. SEER collects mortality data among patients with cancer through selected
population-based cancer registries covering approximately 28 percent of the US population in 17 states.
The inclusion criteria for the study participants were adults (≥18 years old) diagnosed with
primary colorectal cancer using the international classification of diseases (ICD-10) codes for colon and
rectal cancers (C180, C182, C183, C184, C185, C186, C187, C189, C199, and C209) between 2007 and
2014 in the US. People with metastatic colon cancer (cancers that developed metastasis in the colon or
rectum but were not primary colorectal cancers) or missing data in any variable were excluded.
The main outcome of the study was CRC-specific mortality. Race, the main exposure variable,
was included the following racial/ethnic categories: Whites, blacks, Asians/Pacific Islanders, American
Indians, and Alaska Natives. The covariates included in the study were sex, age at diagnosis, marital status,
insurance status, diagnosis stage, tumor grade, and tumor size. Age at diagnosis was categorized into
≥18–50, 51–70, 71–80, and >80 years-old groups. Marital status was registered as married, unmarried
(single, divorced, widowed separated, unmarried or domestic partner) or unknown. Health insurance
was dichotomized into insured (including Medicaid) and uninsured, as per SEER insurance code.
The stage of tumor was classified according to SEER Summary stage 2000 (1998+) as in situ, localized,
regional or distant. Tumor grade was categorized into four different groups: (i) Differentiated;
(ii) moderately differentiated; (iii); poorly differentiated; and (iv) undifferentiated. Tumor size was
reported in SEER as exact size in millimeters. For our analysis, tumor size was dichotomized into less
or above 40 mm according to the median tumor size of the study participants. Information on health
insurance was not available prior to 2007 in SEER; the time span for this study was 2007–2014.
2.2. Statistical Analysis
Stata V. 14 (StataCorp LLC, College Station, TX, USA) was used to conduct all analyses. Exploratory
analysis was carried out by examining frequency distribution. A Chi-square test was used to test
bivariate associations between potential confounders according to race and mortality, respectively.
The covariates of age, sex, age at diagnosis, marital status, insurance status, stage at diagnosis, and tumor
grade and size were found to be differently distributed according to the exposure and outcome variables.
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Thus, the mathematical models were adjusted for these eight variables. Binary logistic regression
was used to estimate unadjusted and adjusted odds ratios (OR) and 95% confidence intervals (CI)
between race and mortality. The main outcome variable was CRC-specific mortality and the main
exposure variable was race. The Hosmer Lemeshow test was applied to test for the goodness-of-fit of
the statistical model. A p-value of less than 0.05 was considered statistically significant.
2.3. Ethical Considerations
Ethical approval was waived, since the analysis was considered nonhuman subjects research by
the Florida International University Health Science Institutional Review Board.
2.4. Data Availability
The Surveillance, Epidemiology, and End Results (SEER) data used to support the findings of
this study were supplied by the National Cancer Institute under license and so cannot be made
freely available. Requests for access to these data should be made to the National Cancer Institute,
https://seer.cancer.gov [15].
3. Results
The total number of participants in this study was 85,796 and after applying exclusion criteria,
the eligible number of participants was 70,392. Table 1 presents the characteristics of the study
population according to race. A statistically significant difference was observed between the
distributions of sex and tumor size according to race. The prevalence of American Indians/Alaskan
natives diagnosed with colorectal cancer between 18 and 50 years of age was 21.8%. Approximately half
of (54%) of blacks were diagnosed at 51–70 years of age, and most of the whites were diagnosed at a late
age (p < 0.001). American Indians/Alaskan natives had a higher percentage of grade I (11.2%) compared
with other race groups (p < 0.001). In addition, Asians/Pacific Islanders had the highest percentage of
Grade II tumor (77.7%) and whites had the highest frequency of grade III and grade IV tumor (16.9%
and 2.7%, respectively) (p < 0.001). About 5.7% of blacks were uninsured, which was higher than the
corresponding prevalence among whites, Asians/Pacific islanders, and American Indians (2.3%, 2.2%,
and 1.5%, respectively). Furthermore, blacks had a higher prevalence of being unmarried (63.3%) than
other races (p < 0.001). Diagnosis stage showed statistically significant differences among colorectal
cancer patients.
Table 1. Characteristics of colorectal cancer patients according race in the US during 2007 and 2014.
Race
White
(n = 54,125)

Black
(n = 8020)

API 1
(n = 7627)

Other 2
(n = 593)

n (%)

n (%)

n (%)

n (%)

Sex
Male
Female

28,382 (52.4)
25,743 (47.6)

3959 (49.4)
4061 (50.6)

4178 (54.8)
3449 (45.2)

303 (53.2)
290 (46.8)

Age at diagnosis
≥18–50 years
51–70 years
71–80 years
>80 years

7174 (13.3)
24,030 (44.4)
12,283 (22.7)
10,638 (19.7)

1371 (17.1)
4357 (54.3)
1411 (17.6)
881 (11)

1158 (15.2)
3762 (49.3)
1574 (20.6)
1133 (14.9)

135 (21.8)
322 (51.9)
117 (18.9)
46 (7.4)

Marital status
Unmarried
Married

21,544 (42.2)
29,533 (57.8)

4720 (63.3)
2733 (36.7)

2580 (36.4)
4511 (63.6)

282 (51.9)
261 (48.1)

Characteristics

p-Value 3

<0.001

<0.001

<0.001
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Table 1. Cont.
Race
White
(n = 54,125)

Black
(n = 8020)

API 1
(n = 7627)

Other 2
(n = 593)

n (%)

n (%)

n (%)

n (%)

Insurance status
Uninsured
Insured

1175 (2.3)
50,960 (97.8)

446 (5.7)
7349 (94.3)

163 (2.2)
7113 (97.8)

9 (1.5)
584 (98.5)

Diagnosis stage
In situ
Localized
Regional
Distant

1705 (3.2)
20,798 (39.3)
20,039 (37.9)
10,393 (19.6)

242 (3.1)
2722 (34.8)
2779 (35.5)
2083 (26.6)

292 (3.9)
2854 (38.4)
2882 (38.7)
1413 (19)

11 (1.8)
214 (35.3)
242 (39.9)
140 (23.1)

Tumor grade
Grade I
Grade II
Grade III
Grade IV

4396 (9.5)
32,988 (71)
7850 (16.9)
1258 (2.7)

564 (8.6)
5029 (76.3)
900 (13.7)
99 (1.5)

475 (7.2)
5116 (77.7)
888 (13.5)
107 (1.6)

60 (11.2)
396 (73.9)
71 (13.3)
9 (1.7)

Tumor size
≤40 mm
≥41 mm

21,564 (50.2)
21,374 (49.8)

2979 (47.2)
3329 (52.8)

3278 (53.2)
2882 (46.8)

200 (42.8)
267 (57.2)

Characteristics

1

p-Value 3

<0.001

<0.001

<0.001

<0.001

Asian or Pacific Islanders; 2 American Indians and Alaska Natives; 3 Chi-square test.

Table 2 presents the characteristics of colorectal cancer patients according to cause-specific mortality.
Black people had a higher mortality (30.3%) in comparison to other races (p < 0.001). Female colorectal
cancer patients died more often than male patients (p = 0.035). Patients with a tumor size ≥41 mm had
a higher mortality compared to those with a tumor size <41 mm (28.9% vs 15.9%; p-value < 0.001).
Furthermore, statistically significant differences in mortality were observed according to marital status,
stage at diagnosis, age groups, and tumor grade as well (p-values < 0.001).
Table 2. Characteristics of colorectal cancer patients according to colorectal cancer specific mortality in
the US during 2007 and 2014.
Alive or Dead Due to Other Cause

Dead

n (%)

n (%)

Race
White
Black
API 2
Other 3

40,928 (75.6)
5587 (69.7)
5946 (78)
441 (71.1)

13,197 (24.4)
2433 (30.3)
1681 (22)
179 (28.9)

Sex
Male
Female

27,814 (75.5)
25,088 (74.8)

9035 (24.5)
8455 (25.2)

Age at diagnosis
≥18–50
51–70
71–80
>80

7735 (78.6)
25,529 (78.6)
11,481 (74.6)
8157 (64.2)

2103 (21.4)
6942 (21.4)
3904 (25.4)
4541 (35.8)

Marital status
Unmarried
Married

20,493 (70.4)
29,086 (78.5)

8633 (29.6)
7952 (21.5)

Characteristics

p-Value 1
<0.001

0.035

<0.001

<0.001
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Table 2. Cont.
Alive or Dead Due to Other Cause

Dead

n (%)

n (%)

Insurance Status
Uninsured
Insured

1200 (66.9)
49,768 (75.4)

593 (33.1)
16,238 (24.6)

Stage at diagnosis
In situ
Localized
Regional
Distant

2203 (97.9)
24,644 (92.7)
20,658 (79.6)
4555 (32.5)

47 (2.1)
1944 (7.3)
5284 (20.4)
9474 (67.5)

Tumor grade
Grade I
Grade II
Grade III
Grade IV

4690 (85.4)
34,363 (78.9)
6076 (62.6)
994 (67.5)

805 (14.7)
9166 (21.1)
3633 (37.4)
479 (32.5)

Tumor size
≤40 mm
≥41 mm

23,571 (84.1)
19,812 (71.1)

4450 (15.9)
8040 (28.9)

Characteristics

1

p-Value 1
<0.001

<0.001

<0.001

<0.001

Chi-square test; 2 Asian or Pacific Islanders; 3 American Indians and Alaska Natives.

Table 3 shows the unadjusted and adjusted associations between race and cancer-specific death.
Blacks had the highest odds for colorectal cancer mortality with a statistically significant 32% increased
odds compared with whites (OR = 1.32; 95% CI 1.22–1.43). The corresponding OR for American
Indians/Alaskan Natives was 1.41 (95% CI 1.10–1.84). The unadjusted OR for mortality in API showed
a lower risk compared with whites (OR = 0.88, 95% CI 0.83–0.93). However, after adjusting for the
covariates (sex, age at diagnosis, tumor size, tumor grade, insurance status, marital status, and diagnosis
stage) the decrease in odds became statistically nonsignificant (OR = 0.95, 95% CI 0.87–1.03). It can
be seen that the confidence intervals of the adjusted odds of blacks is included within the confidence
limits of American Indians/Alaskan Natives, indicating that there are no differences in the odds of
mortality between these two groups. Unmarried (single, divorced, widowed, and separated) patients
had a 54% increase in the odds of mortality compared to married patients (OR = 1.54, 95% CI 1.49–1.60).
Additionally, the odds of mortality in the adjusted logistic regression models in uninsured CRC patients
was 51% higher than in insured patients (OR = 1.51, 95% CI 1.37–1.67).
Table 3. Unadjusted and adjusted associations of the logistic regression models between race and cause
specific death in patients with colorectal cancer in the US during 2007–2014.
Characteristics

Adjusted 1

Unadjusted
2

OR (95% CI

3)

OR (95% CI)

Race
White
Black
API 5
Other 6

Ref 4
1.35 (1.28–1.42)
0.88 (0.83–0.93)
1.26 (1.06–1.50)

Ref
1.32 (1.22–1.43)
0.95 (0.87–1.03)
1.41 (1.10–1.84)

Sex
Male
Female

Ref
1.04 (1.00–1.07)

Ref
0.87 (0.83–0.92)

Age at diagnosis
≥18–50
51–70
71–80
>80

Ref
1.00 (0.95–1.06)
1.25 (1.18–1.33)
2.05 (1.93–2.17)

Ref
1.24 (1.15–1.35)
1.90 (1.74–2.07)
3.17 (2.90–3.47)
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Table 3. Cont.
Unadjusted

Adjusted 1

OR 2 (95% CI 3 )

OR (95% CI)

Marital status
Married
Unmarried

Ref
1.54 (1.49–1.60)

Ref
1.27 (1.20–1.34)

Insurance status
Insured
Uninsured

Ref
1.51 (1.37–1.67)

Ref
1.21 (1.03–1.41)

Tumor grade
Grade I
Grade II
Grade III
Grade IV

Ref
1.55 (1.44–1.68)
3.48 (3.20–3.79)
2.81 (2.46–3.20)

Ref
1.02 (0.92–1.14)
1.74 (1.55–1.95)
1.47 (1.24–1.74)

Diagnosis stage
Localized
In situ
Regional
Distant

Ref
0.27 (0.20–0.36)
3.24 (3.07–3.43)
26.37 (24.88–27.95)

Ref
0.30 (0.11–0.82)
3.19 (2.98–3.42)
23.55 (21.77–25.48)

Tumor size
≤40 mm
≥41 mm

Ref
2.15 (2.06–2.24)

Ref
1.21 (1.15–1.27)

Characteristics

1

Adjusted for the covariates: Sex, age at diagnosis, tumor size, tumor grade, insurance status, marital status,
and diagnosis stage; 2 Odds ratio; 3 Confidence interval; 4 Reference group; 5 Asian or Pacific Islanders; 6 American
Indians and Alaska Natives.

4. Discussion
Our study found disparities between races regarding colorectal cancer-specific mortality. Blacks,
American Indians, and Alaskan Natives had a higher mortality compared with whites.
Previous studies mainly compared blacks or African Americans to whites [16–19]. One study
included Asian Americans and Hispanics but did not include native Americans [18]. However,
Ward et al. included native Americans along with “other” races (African American, white, non-Hispanic
Whites, and Asian/Pacific Islander) [16]. Most of the studies used the SEER database with years
ranging from 1975–2000 and 1992–2000 [16], 1974–1976, 1983–1985, 1995–2001 [17], 1988–2006 [18],
and one study in Delaware, US, investigated trends in CRC screening, incidence, and mortality in
2001 and 2009 [19]. Our study is consistent with the previous studies that blacks had higher CRCrelated mortality compared to whites. Moreover, Aizer et al. reported that African Americans were
more likely to be diagnosed with advanced CRC stages and sought medical therapy less often [18].
Nevertheless, racial disparity in CRC-related mortality persisted independently of CRC tumor stage
and treatment [18].
In a different study, Alexander et al. reviewed epidemiologic studies from the Veterans Affairs
health care system database among other databases and registries and found that even in a setting
where equal access to care and treatment existed, as in Veteran Affairs hospitals, the same finding
persisted [17].
In the US, Delaware created a comprehensive state-wide CRC screening program in 2002 that
included coverage for screening and treatment [19]. Grubbs et al. studied trends in CRC screening,
incidence, and mortality in 2001 and 2009, and found that even though screening and incidence rates
disparities were eliminated in 2009, blacks still had higher mortality rates compared to whites [19].
The disparity in mortality can be explained by various mechanisms, such as insurance, which was
demonstrated by Tawk et al. [14] to have a protective effect. Genetic and biological predisposition are
also possible mechanisms, Agrawal et al. [20] found in their study that microsatellite instability plays a
role in CRC course and prognosis. Duray et al. [21] reported that aged people have CRC with poorer
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prognosis and that could be attributed to weakness and instability of the immune system. Psychosocial
factors are also suggested to have a role, as Li et al. [22] found that unmarried people have a worse
outcome compared to married people.
The present study shows that whites tended to be diagnosed with colorectal cancer late in
their lives. By contrast, American Indians/Alaskan Natives and blacks tended to be diagnosed with
colorectal cancer in younger ages. Literature reported that American Indians/Alaskan Natives had
the tendency to be diagnosed earlier [23]. This might be due to other health risk factors, as American
Indians/Alaska Natives were found to have heavy alcohol drinking and smoking habits in comparison
to whites [24,25]. Heavy alcohol consumption and smoking have been associated with increased risk of
colorectal cancer [26–28]. A study reported that African Americans have the tendency to be diagnosed
with colorectal cancer earlier than others [29]. It is unclear why blacks had the tendency to present
with the disease earlier than others, but it could be explained by multiple factors, such as genetic
and biological predisposition or the current guidelines recommending that cancer screening should
only be started at age of 50 years, which might be late for them [20]. Additionally, studies reported
that there is a higher proportion of right-sided colon cancer among African Americans, which might
obscure screening tests (flexible sigmoidoscopy) and prevent early diagnosis [30–33]. CRC-related
mortality is directly associated with increasing age at time of diagnosis and that was consistent with
the literature [22]. That could be explained by weakened immune response and increased oxidative
stress [21,34]. Unmarried patients were more likely to die of colorectal cancer and had lower survival
rates and this was consistent with Li et al.’s study; this may be attributed to a lack of psychosocial
support [35–37]. Our study also shows that blacks were more likely to be unmarried, compared to
other races. Uninsured patients had increased odds of mortality (OR 1.21, 95% CI 1.03–1.41) compared
to those insured, which was consistent with Tawk et al.’s study. Lin et al. reported that blacks
were less likely to be insured, which is consistent with the findings in our study. To our knowledge,
there has not been a study that investigated the association of colorectal cancer-related mortality and
tumor size. We found that the larger the tumor size, the higher the risk of cancer-related mortality.
Even though we found an association between tumor size and cancer-related mortality, our results
need to be interpreted with caution as we used a median value of tumor size and used a dichotomized
variable for the statistical modeling. Some studies about the association between tumor size and
prognosis have been published [38,39]. In general, tumor size seems to be inversely associated with
survival [38]. However, studies using SEER data also reported an unfavorable effect of small tumor
size on survival in stage-II [38] and T4b [39] colon cancers. Our study also reported that blacks and
American Indians/Alaskan Natives had larger tumor size. This might add to the fact that both races
had increased odds of cancer-related mortality in our study (OR 1.32, 95% CI 1.22–1.43), (OR 1.41,
95% CI 1.10–1.84), respectively. It has been shown that both advanced tumor grades and stages of
colorectal cancers are associated with increased mortality [13]. This was generally supported by our
study as well, revealing that both grade and stage affected the odds of mortality when adjusting for
race, even though higher grades were found among whites that have less mortality. On the other
hand, blacks were more likely be diagnosed with distant colorectal cancer stage, consistent with other
studies [40–42]. The independent effect of grade and stage may cancel each other out in the adjusted
analysis. Another hypothesis may be that blacks are less likely to undergo screening tests and receiving
adequate treatment [43].
Naturally, our study had some limitations: The SEER database does not include data about
socioeconomic status, income, lifestyle, education, comorbidities, and use of screening test or chemotherapy
treatment. Additionally, it only has data from 17 US states’ registries. Asians and Pacific islanders were
grouped as one entity, but they may have different genetic and risk factors. Furthermore, genetic and
biological data are not incorporated in the database.
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5. Conclusions
In conclusion, our study reveals blacks had the highest CRC-related mortality among all races
included in the study compared to whites. Demographic features and tumor characteristics may play
a role in the disparity of CRC-related mortality. The establishment of early screening for high-risk
groups might overcome those disparities. We also recommend awareness programs targeted at
those with a higher risk of CRC to encourage early screening and adherence to screening programs.
Additionally, further research is needed to investigate the reasons for delayed screening in at-risk
groups. Other studies focusing on behavior, lifestyle, knowledge, and attitude should be done to
further explain the disparities in the outcome. Due to the higher proportion of right-sided tumors,
diagnostic tools should put emphasis on covering the whole colon.
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